Overview:
The Cleveland Clinic Thyroid Expo 2026 is a comprehensive, one-day educational course focused on the latest advances in the diagnosis, treatment, and management of thyroid diseases, with particular emphasis on innovations in thyroid cancer care.
This specialized program provides healthcare professionals with practical, evidence-based updates on contemporary thyroid management, including primary hypothyroidism, complex treatment considerations in patients with malabsorption, differentiated thyroid carcinoma, and advanced thyroid cancer.
The course explores the clinical application of the 2025 American Thyroid Association (ATA) guidelines, advances in thyroid pathology and molecular testing, and emerging multidisciplinary approaches to aggressive thyroid malignancies. Participants will also examine modern radiation therapy techniques, neoadjuvant treatment strategies, thyroid ultrasound applications, percutaneous procedures, and the evolving management of thyroid eye disease.
Featuring a keynote educational session on differentiated thyroid cancer, the program offers valuable insights into current clinical guidelines, risk stratification, diagnostic innovations, and personalized treatment approaches.
Through expert-led presentations, practical clinical discussions, and interactive case-based sessions, participants will gain knowledge that can be applied to everyday clinical practice and complex patient management.
Why Attend?
This educational course offers a focused opportunity to explore important developments in thyroid disease management and thyroid cancer treatment.
Participants will benefit from:
-
Up-to-date reviews of evidence-based approaches to primary hypothyroidism.
-
Practical treatment considerations for patients with malabsorption.
-
Clinical applications of the 2025 American Thyroid Association guidelines.
-
Advances in differentiated and advanced thyroid cancer management.
-
Updates on thyroid pathology, molecular testing, and cancer risk stratification.
-
Emerging multidisciplinary and neoadjuvant treatment strategies for aggressive thyroid cancer.
-
Modern radiation therapy techniques and treatment outcomes.
-
Practical applications of point-of-care thyroid ultrasound and real-time imaging.
-
Advances in percutaneous thyroid procedures.
-
Current understanding of thyroid eye disease and its medical management.
-
Interactive clinical case discussions and multidisciplinary perspectives.
Featured Keynote Session
Differentiated Thyroid Cancer: 2025 ATA Guidelines and Clinical Applications
The symposium features a keynote educational session led by Matthew Ringel, MD, Professor and Chair of Molecular Medicine and Therapeutics at The Ohio State University College of Medicine and Co-Chair of the American Thyroid Association task force responsible for the newly released thyroid cancer guidelines.
This session will provide a focused overview of differentiated thyroid cancer, emphasizing the clinical implications of the 2025 ATA guidelines and their application to contemporary patient care.
Participants will gain insights into evolving diagnostic recommendations, pathology, risk stratification, and evidence-based treatment strategies for differentiated thyroid carcinoma.
Who Should Attend?
This course is designed for a multidisciplinary audience of healthcare professionals involved in the diagnosis, treatment, and management of thyroid diseases.
The intended audience includes:
-
-
-
-
-
-
-
-
-
-
-
-
-
Primary Care Professionals
-
Other healthcare professionals involved in thyroid disease management
Learning Objectives
Upon completion of this educational activity, participants will be able to:
1. Apply Evidence-Based Hypothyroidism Management: Implement current clinical evidence and guideline-based strategies for diagnosing and managing primary hypothyroidism, including treatment considerations for patients with malabsorption.
2. Evaluate Radiation Therapy and Thyroid Eye Disease: Assess the indications, effectiveness, and outcomes of modern radiation therapy techniques and explain the underlying pathophysiology and medical management of thyroid eye disease.
3. Understand Advanced Thyroid Cancer Treatment: Evaluate multidisciplinary and emerging treatment approaches for advanced and aggressive differentiated thyroid cancer, including neoadjuvant therapies and the role of caregivers in patient management.
4. Apply the 2025 ATA Guidelines: Integrate pathological and molecular characteristics of differentiated thyroid carcinoma into clinical decision-making, risk stratification, and treatment planning in accordance with the 2025 American Thyroid Association guidelines.
5. Utilize Thyroid Ultrasound: Interpret and apply point-of-care thyroid ultrasound findings to support clinical decision-making, including real-time assessment and percutaneous procedures.
Program Agenda and Educational Topics
Thursday, October 8, 2026
The one-day educational program includes the following sessions and activities:
Primary Thyroid Disorders and Medical Management
-
Primary Hypothyroidism: Practical Treatment Decisions in Real Patients
-
Evidence-Based Treatment Strategies
-
Management Considerations for Patients with Malabsorption
Differentiated Thyroid Cancer and Clinical Guidelines
-
2025 American Thyroid Association Differentiated Thyroid Cancer Guidelines: Applications for Clinical Practice
-
Further De-escalation in the Treatment of Differentiated Thyroid Carcinoma
-
The Importance of Pathology in Thyroid Cancer Management
-
Molecular Testing and Clinical Risk Stratification
Advanced Thyroid Cancer Management
-
Management of Advanced Thyroid Cancer
-
Emerging Treatment Strategies for Aggressive Differentiated Thyroid Cancer
-
Integration of External Beam Radiation Therapy into Current and Emerging Treatment Approaches
-
Radiation Therapy Outcomes and Multidisciplinary Treatment Planning
Thyroid Imaging and Diagnostic Innovations
-
Practical Tips and Techniques in Point-of-Care Thyroid Ultrasound
-
Real-Time Thyroid Imaging and Clinical Assessment
-
Applications of Ultrasound-Guided Percutaneous Procedures
Thyroid Eye Disease
-
Medical Management of Thyroid Eye Disease
-
Pathophysiology and Clinical Considerations
-
The Endocrinologist's Perspective on Thyroid Eye Disease Management
Interactive Clinical Education
-
Case-Based Educational Session
-
Multidisciplinary Panel Discussion
-
Clinical Applications and Patient Management Strategies
Closing Session
-
-
Program Conclusion and Adjournment
Key Educational Highlights
The Cleveland Clinic Thyroid Expo 2026 emphasizes several important areas of contemporary thyroid medicine:
-
Evidence-Based Endocrine Care: Current approaches to diagnosing and treating primary hypothyroidism.
-
2025 ATA Guidelines: Practical implementation of updated recommendations for differentiated thyroid cancer.
-
Thyroid Cancer Pathology: The role of pathological evaluation and molecular characteristics in treatment decisions.
-
Advanced Cancer Management: Emerging therapeutic strategies for aggressive and advanced thyroid malignancies.
-
Radiation Oncology: Integration of external beam radiation therapy into thyroid cancer treatment.
-
Thyroid Ultrasound: Point-of-care imaging and real-time diagnostic applications.
-
Percutaneous Procedures: Contemporary image-guided approaches to thyroid disease management.
-
Thyroid Eye Disease: Understanding disease mechanisms and current medical treatment strategies.
-
Multidisciplinary Collaboration: Integrating expertise across endocrinology, surgery, pathology, genetics, immunology, and oncology.
Why This Course Matters
Thyroid diseases and thyroid cancer require an evolving understanding of diagnostic technologies, clinical guidelines, and individualized treatment strategies.
The Cleveland Clinic Thyroid Expo 2026 brings these essential developments together in a focused educational program designed to support clinical excellence and improve patient care.
By combining evidence-based presentations, practical diagnostic techniques, emerging treatment approaches, and interactive case discussions, this course provides healthcare professionals with valuable knowledge applicable to both routine thyroid conditions and complex thyroid cancer cases.
Expand your knowledge of modern thyroid care and explore the latest advances in thyroid cancer diagnosis, treatment, and multidisciplinary management through the Cleveland Clinic Thyroid Expo 2026.